로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Integrin alpha 4 beta 1

Integrin alpha 4 beta 1

요약

Name:Integrin alpha-4/beta-1
Target Synonym:Integrin alpha4beta1
Number of Launched Drugs:3
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Approved

제품 리스트 구매

일부의 생물활성 데이터

IT1-H82W1-SPR
 Integrin alpha 4 beta 1 SPR

Human VCAM-1, His Tag (Cat. No. VC1-H5224) immobilized on CM5 Chip can bind Biotinylated Human ITGA4&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82W1) with an affinity constant of 253 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

IT1-H52W1-SPR
 Integrin alpha 4 beta 1 SPR

Human VCAM-1, His Tag (Cat. No. VC1-H5224) immobilized on CM5 Chip can bind Human ITGA4&ITGB1 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT1-H52W1) with an affinity constant of 51.3 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Synonym Name

Integrin alpha 4 beta 1,ITGA4&ITGB1,ITGA4&B1

Background

Integrins are transmembrane proteins that mediate interactions between adhesion molecules on adjacent cells and/or the extracellular matrix (ECM). Integrins have diverse roles in several biological processes including cell migration during development and wound healing, cell differentiation, and apoptosis. Their activities can also regulate the metastatic and invasive potential of tumor cells. Integrin alpha 4 beta 1(Alpha-4/beta-1) is receptors for fibronectin. Integrin alpha-4/beta-1 is a receptor for VCAM1 and recognizes the sequence Q-I-D-S in VCAM1.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Carotegrast methyl AJM-300 Approved Ea Pharma, Eisai Co Ltd Carogra Japan Colitis, Ulcerative Ea Pharma Co Ltd 2022-03-28 Colitis, Ulcerative Details
Natalizumab biosimilar(Polpharma Biologics) PB-006; DST-356A1 Approved Polpharma Biologics Sa Tyruko United States Multiple Sclerosis; Crohn Disease Sandoz Inc 2023-08-24 Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Crohn Disease Details
Natalizumab BG-0002; TY-21.6; AN-10022; BG-00002; AN-100226; BG-0002-E Approved Biogen Inc, Perrigo Llc Tysabri, Antegran, Antegren United States Crohn Disease; Multiple Sclerosis Biogen Idec 2004-11-23 Multiple Sclerosis, Relapsing-Remitting; Epilepsies, Partial; Arthritis, Rheumatoid; Graft vs Host Disease; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Multiple Myeloma; Myositis, Inclusion Body; Demyelinating Diseases; Ischemic Stroke; Crohn Disease Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Natalizumab biosimilar (GENERIUM Pharmaceuticals) GNR-093 Phase 3 Clinical Generium Pharmaceuticals Multiple Sclerosis Details
AS-101 PRX-0001/AS101; WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101 Phase 2 Clinical Biomas Ltd HIV Infections; Alopecia; Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Condylomata Acuminata; Dermatitis, Atopic; Macular Degeneration Details
ATL-1102 ATL-1102; ATL/TV-1102; ISIS-107248; TV-1102 Phase 2 Clinical Ionis Pharmaceuticals Inc Multiple Sclerosis; Muscular Dystrophy, Duchenne Details
Alintegimod 7HP349; 7-HP-349; 7HP-349 Phase 2 Clinical 7 Hills Pharma LLC Kidney Neoplasms; Solid tumours; Carcinoma, Renal Cell; Mismatch Repair Deficient Cancer; Skin Neoplasms; Neoplasms; Coronavirus Disease 2019 (COVID-19); Mesothelioma; Tuberculosis; Influenza, Human; Colorectal Neoplasms; Chagas Disease; Carcinoma, Hepatocellular; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Melanoma Details
LLP2A alendronate Phase 1 Clinical University Of California Osteonecrosis; Bone Diseases, Metabolic; Osteoporosis; Bone Diseases Details
RBx-7796 RBx-7796 Clinical Sun Pharmaceutical Industries Ltd Rhinitis, Allergic; Asthma Details

This web search service is supported by Google Inc.

totop